Diagnosis of hepatitis C virus‐associated chronic liver disease in India: Comparison of HCV antibody assay with a polymerase chain reaction for the 5′ noncoding region
- 1 October 1994
- journal article
- clinical trial
- Published by Wiley in Journal of Medical Virology
- Vol. 44 (2) , 176-179
- https://doi.org/10.1002/jmv.1890440211
Abstract
The relative value of an anti‐hepatitis C virus (HCV) serological assay and reverse transcriptase‐nested polymerase chain reaction assays (RT‐PCR) were investigated for the constant 5′ putative noncoding region of HCV for the diagnosis of HCV‐associated chronic liver diseases in India. One hundred fifteen patients with biopsy proven chronic active hepatitis and 140 cases of cirrhosis of the liver were investigated for anti HCV antibody using a second generation commercial enzyme‐linked immunosorbent assay (ELISA). A proportion of these patients: 42 with chronic hepatitis and 27 with cirrhosis of the liver were analysed further for HCV RNA in the serum using RT‐nested PCR assay. Thirty‐three (12.9%) of the 255 patients were positive for anti‐HCV antibody and 23 of 69 (33.3%) patients were positive for HCV RNA in serum. Fifteen of the 33 (45.5%) anti‐HCV positive patients had HCV RNA in the serum. Eight of 36 (22.2%) HCV seronegative patients tested were found with HCV RNA. This indicates that the diagnosis of HCV infection is not possible if it is based solely on the available serodiagnostic tests. Inclusion of both assays improved the diagnostic efficiency, 18.8% (13/69) were negative for all virological markers associated with HBV and HCV infection. Since a majority of the chronic liver disease patients (143/255 [56%]) were seronegative for either HBV or HCV infection, it is significant that HCV RNA was detected in 38% (8/21) of a randomly selected group from these patients. The antibody assay and PCR were compared using interclass correlation (kappa statistics). Both these tests were found to be independent of each other. Considering the wide strain variation throughout the world, it is suggested that the current commercial anti‐HCV testing is inadequate for the diagnosis of all HCV infections in all geographical regions.Keywords
This publication has 15 references indexed in Scilit:
- Hepatitis C virus antibodies in acute and chronic liver disease in IndiaJournal of Hepatology, 1993
- Prevalence of hepatitis C virus antibodies in chronic liver disease and hepatocellular carcinoma patients in IndiaJournal of Gastroenterology and Hepatology, 1992
- Overestimation of the prevalence of antibody to hepatitis C virus in retrospective studies on stored seraHepatology, 1991
- Intraobserver and interobserver variation in the histopathological assessment of liver allograft rejectionHepatology, 1991
- Hepatitis C Virus Antibody in Acute and Chronic Liver Diseases in IndiaScandinavian Journal of Infectious Diseases, 1990
- ANTI-HEPATITIS C ANTIBODIES AND NON-A, NON-B POST-TRANSFUSION HEPATITIS IN THE NETHERLANDSThe Lancet, 1989
- HEPATITIS C VIRUS ANTIBODIES AMONG RISK GROUPS IN SPAINThe Lancet, 1989
- An Assay for Circulating Antibodies to a Major Etiologic Virus of Human Non-A, Non-B HepatitisScience, 1989
- Non-A, Non-B Hepatitis: Evolving Epidemiologic and Clinical PerspectiveSeminars in Liver Disease, 1986
- A Coefficient of Agreement for Nominal ScalesEducational and Psychological Measurement, 1960